Background
==========

Infectious bursal disease virus (IBDV) is the etiologic agent of infectious bursal disease (IBD), an acute and highly contagious disease affecting young chickens. Characterized by immunosuppression and a high rate of mortality, this disease causes a huge economic loss to the poultry industry worldwide \[[@B1]\]. In recent years, IBD has rarely showed the typical clinical symptoms and become less responsive to the conventional vaccination. Very virulent IBDV (vvIBDV) causing severe mortality in chickens has become the dominant strain responsible for several disease outbreaks in China \[[@B2]\]. To control this disease, a sensitive, reliable, rapid and clinically feasible method for the detection of the virus and identification of the very virulent strain at early stage of infection is urgently needed.

Developed by Notomi et al., loop-mediated isothermal amplification (LAMP) is a novel DNA amplification method with high specificity and sensitivity under isothermal condition \[[@B3]\]. It is also a robust method that produces a high amount of products sufficient for real time monitoring by visual inspection. In addition, RNA can be directly used as starting material by reverse transcription coupled with loop-mediated isothermal amplification (RT-LAMP) in one step \[[@B4]-[@B8]\], making it ideal for detection of RNA-viruses such as IBDV. Previously, in a field diagnostic testing, RT-LAMP showed great superiority over conventional RT-PCR \[[@B9],[@B10]\]. More recently, it has been successfully applied for the detection of IBDV \[[@B11],[@B12]\]. However, none of these studies differentiated virus types.

In this study, we applied RT-LAMP to detect IBDV in one simple step and further identified the very virulent strain from the non-vvIBDVs with a post-amplification restriction digestion analysis. We show here that this method is very efficient and convenient compared with conventional RT-PCR and real-time RT-PCR, and also high feasible with clinical specimens.

Methods
=======

Virus strains
-------------

IBDV Gt strain was attenuated from the vvIBDV Gx strain through continuous passage in specific-pathogen-free chicken embryos for 5 generations and in chicken embryo fibroblasts for 20 generations \[[@B13]\]. IBDV Gt, IBDV D78, vvIBDV Gx and chicken anemia virus (CAV) M9905 were all stock strains of our laboratory. Other avian pathogens, such as avian influenza virus (AIV) A/Chicken/Shandong/6/96 (H9N2), Newcastle disease virus (NDV) La sota, infectious bronchitis virus (IBV) F and Marek\'s disease virus (MDV) CV1988 were obtained from the Harbin Veterinary Research Institute, China.

Sequence analysis and primer design
-----------------------------------

Sequence data for 57 IBDV isolates including vvIBDVs (GenBank accession numbers: \[[AF092943](AF092943)\], \[[AF240686](AF240686)\], \[[AF247006](AF247006)\], \[[AF262030](AF262030)\], \[[AF322444](AF322444)\], \[[AF362776](AF362776)\], \[[AF508176](AF508176)\], \[[AF527039](AF527039)\], \[[AF533670](AF533670)\], \[[AJ318896](AJ318896)\], \[[AJ879932](AJ879932)\], \[[AY099456](AY099456)\], \[[AY134874](AY134874)\], \[[AY323952](AY323952)\], \[[AY444873](AY444873)\], \[[AY520909](AY520909)\], \[[AY520910](AY520910)\], \[[AY520911](AY520911)\], \[[AY598356](AY598356)\], \[[AY665672](AY665672)\], \[[AY769978](AY769978)\], \[[AY780418](AY780418)\], \[[D49706](D49706)\], \[[DQ286035](DQ286035)\], \[[DQ927042](DQ927042)\], \[[EF517528](EF517528)\]) and non-vvIBDVs (GenBank accession numbers: \[[AF006694](AF006694)\], \[[AF051837](AF051837)\], \[[AF109154](AF109154)\], \[[AF133904](AF133904)\], \[[AF194428](AF194428)\], \[[AF321054](AF321054)\], \[[AF321055](AF321055)\], \[[AF362747](AF362747)\], \[[AF362771](AF362771)\], \[[AF362773](AF362773)\], \[[AF499929](AF499929)\], \[[AJ310185](AJ310185)\], \[[AY029166](AY029166)\], \[[AY319768](AY319768)\], \[[AY368653](AY368653)\], \[[AY462026](AY462026)\], \[[AY918948](AY918948)\], \[[AY918950](AY918950)\], \[[D00499](D00499)\], \[[D00867](D00867)\], \[[D00868](D00868)\], \[[D00869](D00869)\], \[[DQ187988](DQ187988)\], \[[DQ403248](DQ403248)\], \[[EF418033](EF418033)\], \[[EF418034](EF418034)\], \[[EF418035](EF418035)\], \[[M66722](M66722)\], \[[X03993](X03993)\], \[[X16107](X16107)\], \[[X84034](X84034)\]) were retrieved from GenBank, and analyzed with the sequence analysis software MegAlign (DNAStar Inc., Madison, WI, USA). Sequence alignment was performed using the Clustal W multiple sequence alignment program. The sequence encoding the VP5 protein was chosen as the target sequence for RT-LAMP. Six primers specific for the VP5 gene including two outer primers (F3 and B3), two inner primers (FIP and BIP) and two loop primers (LF and LB) were designed with the Primer Explorer V4 software (<https://primerexplorer.jp>) (Figure [1](#F1){ref-type="fig"}).

![**Primer design for RT-LAMP to detect IBDV based on the VP5 gene of Gx strain**. (A). Genomic DNA sequence of vvIBDV Gx strain (GenBank Accession number: \[[AY444873](AY444873)\]) VP5 gene from 181 to 417 nt in orientation 5\' to 3\'. Nucleotide sequences used for the primers are highlighted with grey background, and the arrows indicate the 5\' to 3\' direction of the primers. The open box shows the Tfi I restriction site exclusively located in non-vvIBDVs. (B). A table listing the names and sequences of all 6 primers.](1743-422X-8-108-1){#F1}

RNA extraction
--------------

Viral RNA was extracted using TRIzol Reagent (Invitrogen, USA) according to manufacturer\'s instructions. RNA was dissolved in 20 μL DEPC-treated water, and stored at -70°C before use.

RT-LAMP reaction
----------------

The RT-LAMP reaction was carried out using a Loopamp RNA amplification kit (Eiken Chemical Co., Ltd, Tokyo, Japan). Each 25 μL reaction contained 1.6 μM of each inner primer (FIP and BIP), 0.8 μM of each loop primer (LF and LB), 0.2 μM of each outer primer (F3 and B3), and 2 μL template RNA. In the reaction, 1 μL of fluorescent reagent FDR (Eiken Chemical Co., Ltd, Tokyo, Japan) was added to detect amplified products. After initial optimization of reaction conditions under different temperatures (61-65°C) for various times (15-60 min), a 65°C incubation for 60 minutes yielded the best result (not shown), therefore, all the LAMP reactions in the study presented in \"Results\" were carried out at 65°C for 1 hour, and inactivated at 80°C for 10 min.

The RT-LAMP product was analyzed by agarose gel electrophoresis and also visually inspected for the color change from orange color to bright green. For electrophoresis, 10 μL aliquot of RT-LAMP product was separated on a 2% agarose gel, stained with ethidium bromide, and photographed under a UV transilluminator. For the visual inspection, the tubes were observed by naked eyes and photographed under the natural light. The color of a negative control reaction should have remained orange.

Specificity test
----------------

To evaluate the cross-reactivity of the VP5 primer set with other common avian pathogens, samples extracted from AIV, NDV, IBV, MDV and CAV strains were tested together with vvIBDV Gx strain and a DEPC-treated water negative control under the same conditions

Sensitivity test
----------------

To evaluate the sensitivity of RT-LAMP, RNA standards were in vitro transcribed with T7 Cap-Scribe (Roche, Germany) from plasmid pcDNA3.1-GtVP5 carrying the VP5 gene of Gt strain under the control of T7 promoter. RNA was quantified by spectrophotometer, and then 10-fold serially diluted from 2.8 × 10^5^copies/μL to 2.8 × 10^0^copies/μL and used as templates for RT-LAMP. The lowest amount of RNA detectable under the conditions described above was defined as the detection limit.

Identification of vvIBDV by Tfi I restriction fragment analysis
---------------------------------------------------------------

RT-LAMP products were digested with Tfi I in a 20 μL reaction containing 3 μL RT-LAMP product, 1 × NEBuffer 3, 1 × BSA and 2.5 U TfiI (New England Biolabs, USA). After incubation at 65°C for 1 hour, 10 μL aliquot was subjected to electrophoresis on 2% agarose gel and stained with ethidium bromide. The DNA band pattern was visualized with a UV transilluminator and photographed.

Clinical specimen evaluation
----------------------------

From 1999 to 2008, samples from Bursa of Fabricius in chickens exhibiting skeptical pathologic features of IBD were collected in different commercial broiler and layer farms from 11 provinces of China. All specimens were processed according to the International Cooperation with Developing Countries project method. Tissues were homogenized as described previously \[[@B2]\]. Viral RNA extraction, RT-LAMP, product analysis and Tfi I digestion were carried out essentially the same as described above.

### Reverse transcription

12 μL viral RNA and the segment specific primer R (5\'-CCATTGTAGCTAACATCTGTC-3\') were denatured at 95°C for 5 min and chilled immediately on ice for 2 min. Reverse transcription was performed in a 20 μL containing 12 μL RNA, 4 μL of 5 × FS buffer (Invitrogen, USA), 1 μL of dNTP (10 mM each), 1 μL of DTT (0.1 M), 1 μL of specific primer R (5\'-CCATTGTAGCTAACATCTGTC-3\' 50 μM), 100 U of Superscript™ III; Reverse Transcriptase (Invitrogen, USA), 20 U of RNase Inhibitor (TaKaRa, China). Reaction was carried out at 50°C for 1 h and 70°C for 15 min. 2 μL cDNA was used in conventional PCR and real-time PCR reactions below.

### PCR

using a pair of primers (F: 5\'-GCGAATTCGGATACGATCGGTCTG-3\'; R: 5\'-CCATTGTAGCTAACATCTGTC-3\') and Ex Taq polymerase (TaKaRa, China), a conventional PCR was carried out with a pre-denaturation at 95°C for 5 min and 30 cycles of 94°C for 30 sec, 50°C 30 sec, 72°C for 45 sec, followed by 72°C for 7 min. PCR product was electrophoresed on 1% agarose gel and stained with ethidium bromide. The correct amplification product showed as a DNA band of bout 560 bp.

### Real-time PCR

the TaqMan based real-time PCR was performed in a total volume of 25 μL as described in our previous paper \[[@B14]\], and the reaction was performed with a pre-denaturation at 95°C for 5 min, and 40 cycles of denaturation at 95°C for 10 sec and annealing/elongation at 60°C for 40 sec. Fluorescent signal measurements were carried out during the elongation step.

Results
=======

Specificity and Sensitivity of the RT-LAMP
------------------------------------------

As shown in Figure [2A](#F2){ref-type="fig"}, RT-LAMP products of RNA from vvIBDV Gx showed a ladder-like pattern on the gel. The reaction also caused change of turbidity, the color inside the tube changed from orange to green that was easily visible to naked eyes under the natural light. The reactions containing samples of common avian pathogens AIV, NDV, IBV, MDV and CAV as well as the negative control showed no product on the gel. Consistently, the color of these negative reactions remained orange.

![**Specificity and sensitivity of RT-LAMP for the detection of IBDV**. (A) Five related avian pathogens and vvIBDV Gx strain were subjected to RT-LAMP using the primers shown in Figure 1, and the RT-LAMP products were examined by both agarose gel electrophoresis (upper panel) and visually inspection for color changes (lower panel). Lanes M, DNA marker DL2000 (TaKaRa, China, with bands of 2000, 1000, 750, 500, 250 and 100 bp); 1, vvIBDV Gx strain; 2, avian influenza virus A/Chicken/Shandong/6/96 (H9N2) strain; 3, Newcastle disease virus La sota strain; 4, infectious bronchitis virus F strain; 5, Marek\'s disease virus CV1988 strain; 6, chicken anemia virus M9905 strain; 7, DEPC-treated water. (B) RNA standards in vitro transcribed and serially diluted were subjected to RT-LAMP and the RT-LAMP products were examined by both agarose gel electrophoresis (upper panel) and visually inspection for color changes (lower panel). Lanes M, DNA marker DL2000 (TaKaRa, China); 1-6, 2.8 × 10^5^, 2.8 × 10^4^, 2.8 × 10^3^, 2.8 × 10^2^, 2.8 × 10^1^and 2.8 × 10° copies of RNA, respectively; 7, DEPC-treated water.](1743-422X-8-108-2){#F2}

Upon 10-fold serial dilution, RNA standards with known copy numbers (2.8 × 10^5^copies/μL to 2.8 × 10° copies/μL) were used for RT-LAMP. As shown in Figure [2B](#F2){ref-type="fig"}, RT-LAMP successfully detected as little as 28 copies of RNA molecules, determined by both the agarose gel electrophoresis and color change inspection.

From the above two sets of experiments, a good correlation between results from the gel images and that from the color change was observed.

Tfi I mediated vvIBDV discrimination
------------------------------------

Sequence analysis based on 26 isolates of vvIBDV and 31 isolates of non-vvIBDV revealed a unique Tfi I restriction site (^5\'^GAWTC^3\'^W = A or T) located between the F1c and B1c regions, and significantly, this site exists exclusively in non-vvIBDVs including typical classical, variant and attenuated strains, therefore, this Tfi I restriction site determined by a single nucleotide polymorphism (SNP) can discriminate vvIBDVs from non-vvIBDVs (Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}). After digestion of RT-LAMP products with the Tfi I, as expected, vvIBDV and non-vvIBDV showed different restriction patterns on agarose gel. After 1 hour digestion, a new 102 bp fragment was observed in sample from Gt strain but not in that of Gx (Figure [3](#F3){ref-type="fig"}). After digestion for as long as 15 hours, sample from vvIBDV Gx retained its ladder-like DNA band pattern on the gel (not shown).

###### 

Nucleotide sequences of vvIBDVs at the TfiI site.

  Strains/isolates   Accession number   Geographic origin   Nucleotides at the restriction site
  ------------------ ------------------ ------------------- -------------------------------------
  Gx                 AY444873           China               G T T T C^Note^
  Harbin-1           EF517528           China               . . . . .
  SH95               AY134874           China               . . . . .
  GZ/96              AY598356           China               . . . . .
  HK46               AF092943           Hongkong            . . . . .
  Chinju             AF508176           Korea               . . . . .
  SH/92              AF533670           Korea               . . . . .
  OKYM               D49706             Japan               . . . . .
  SDH1               AY323952           Iran                . . . . .
  BD 3/99            AF362776           Bangladesh          . . . . .
  UPM97/61           AF247006           Malaysia            . . . . .
  UPM94/273          AF527039           Malaysia            . . . . .
  UPM92-04           AF262030           Malaysia            . . . . .
  B00/73             AY520909           Malaysia            . . . . .
  B00/81             AY520910           Malaysia            . . . . .
  94230              AY520911           Malaysia            . . . . .
  Tasik94            AF322444           Indonesia           . . . . .
  T09                AY099456           Nigeria             . . . . .
  PO7                AY665672           Tunisia             . . . . .
  ks                 DQ927042           Israel              . . . . .
  UK661              AJ318896           U.K.                . C . . .
  02015.1            AJ879932           France              . . . . .
  D6948              AF240686           Netherlands         . . . . .
  Ipumirim-BR        AY769978           Brazil              . . . . .
  SM-BR              AY780418           Brazil              . . . . .
  MG7                DQ286035           Brazil              . . . . .

^Note^The TfiI site was ^5\'^GAWTC^3\'^W = A or T. Dark dot indicated residue which was identical to the vvIBDV Gx. There was no TfiI site in vvIBDVs.

###### 

Nucleotide sequences of non-vvIBDVs at the TfiI stie.

  Strains/isolates   Accession number   Geographic origin   Phenotype      Nucleotides in the restriction site
  ------------------ ------------------ ------------------- -------------- -------------------------------------
  Gt                 DQ403248           China               Attenuated     G A T T C^Note^
  HZ2                AF321054           China               Attenuated     . . . . .
  JD1                AF321055           China               Attenuated     . . . . .
  CJ801bkf           AF006694           China               Attenuated     . . . . .
  GZ29112            AF051837           China               Attenuated     . . . . .
  NB                 AY319768           China               Attenuated     . . . . .
  CEF94              AF194428           Netherlands         Attenuated     . . . . .
  D78                AF499929           Luxembourg          Attenuated     . . . . .
  CT                 AJ310185           France              Attenuated     . . . . .
  Cu-1 M             AF362771           Germany             Attenuated     . . . . .
  P2                 X84034             Germany             Attenuated     . . . . .
  Edgar T            AY462026           USA                 Attenuated     . . . . .
  002-73             X03993             Australia           Classical      . . . . .
  CU-1               X16107             Germany             Classical      . . . . .
  CS-2-35            EF418033           USA                 Classical      . . . . .
  GA-1               EF418034           USA                 Classical      . . . . .
  H-30               EF418035           USA                 Classical      . . . . .
  P3009              AF109154           Taiwan              Classical      . . . . .
  A-BH83             DQ187988           Brazil              Classical      . . . . .
  STC                D00499             USA                 Classical      . . . . .
  Cu1                D00867             Germany             Classical      . . . . .
  PBG-98             D00868             U. K.               Classical      . . . . .
  52/70              D00869             U. K.               Classical      . . . . .
  IM                 AY029166           USA                 Classical      . . . . .
  Cu-1 wt            AF362747           Germany             Classical      . . . . .
  Lukert             AY918948           USA                 Classical      . . . . .
  Edgar C            AY918950           USA                 Classical      . . . . .
  GLS                AY368653           USA                 Variant        . . . . .
  varient E          AF133904           USA                 Variant        . . . . .
  23/82              AF362773           U. K.               Serotype II;   . . . . .
  OH                 M66722             Canada              Serotype II;   . . . . .

^Note^The TfiI site was ^5\'^GAWTC^3\'^W = A or T. Dark dot indicated residue which was identical to the attenuated Gt. There was a TfiI site in non-vvIBDVs.

![**Different Tfi I restriction patterns of RT-LAMP products of vvIBDV Gx and attenuated Gt strains**. RT-LAMP products were digested by Tfi I and subjected to a 2% agarose gel. After ethidium bromide staining, DNA band patterns were photographed under a UV transilluminator. Lanes M, DNA marker DL2000 (TaKaRa, China, with 2000, 1000, 750, 500, 250 and 100 bp bands); 1, RT-LAMP product of Gx digested by Tfi I; 2, RT-LAMP product of Gt digested by Tfi I.](1743-422X-8-108-3){#F3}

Evaluation of RT-LAMP for clinical specimens
--------------------------------------------

To evaluate the feasibility of RT-LAMP for detecting IBDV in clinical specimens, 48 clinical specimens were obtained from a wide range of geographic locations and assayed by RT-LAMP. In parallel, conventional RT-PCR and real-time RT-PCR were also performed. As summarized in Table [3](#T3){ref-type="table"}, percentage of positive samples detected by conventional RT-PCR, real-time RT-PCR and RT-LAMP were 79.2%, 95.8% and 95.8%, respectively. The results of RT-LAMP and real-time RT-PCR were 100% correlated and the correlation between RT-LAMP and conventional RT-PCR was 83.3%.

###### 

Detection rates of clinical specimens by RT-PCR, real-time RT-PCR and RT-LAMP

  Source (NO. of specimens)   RT-PCR   real-time RT-PCR   RT-LAMP                
  --------------------------- -------- ------------------ --------- ----- ------ -----
  Hei Longjiang (18)          17       1                  18        0     18     0
  Shan Dong (9)               6        3                  8         1     9      0
  Ji Lin (6)                  6        0                  6         0     6      0
  Jiang Su (2)                1        1                  2         0     1      1
  Jiang Xi (1)                0        1                  1         0     1      0
  Shang Hai (1)               1        0                  1         0     1      0
  Guang Xi (1)                1        0                  1         0     1      0
  Yun Nan (1)                 1        0                  1         0     1      0
  Hu Nan (1)                  1        0                  1         0     1      0
  Hu Bei (1)                  1        0                  1         0     1      0
  Fu Jian (1)                 1        0                  1         0     1      0
  \-^a^(6)                    2        4                  5         1     5      1
  Total (48)                  38       10                 46        2     46     2
  Percent (%)                 79.2     20.8               95.8      4.2   95.8   4.2

^a^indicates unknown background information on the specimens.

The RT-LAMP products of the 46 positive specimens were subsequently digested by Tfi I together with those from the vvIBDV control Gx and non-vvIBDV control D78. Among those, only one clinical specimen showed a 102 bp fragment as well as the negative control from non-vvIBDV D78 (not shown), indicating that 97.8% (45/46) of the infected specimens or 93.8% (45/48) of total specimens were infected by vvIBDV.

Discussion
==========

In this study, we developed a RT-LAMP assay for the detection of IBDV and subsequent discrimination of vvIBDV based on a SNP site in its VP5 gene. The use of loop primers in this assay greatly accelerates the reaction \[[@B15]-[@B20]\]. We show here that the primers did no cross react with a panel of other common avian pathogens, and the assay had a high sensitivity with the detection limit of 28 copies, which is almost as sensitive as a real-time RT-PCR-based assay for the same virus we developed in the earlier study \[[@B14]\] and 100 times greater than the conventional RT-PCR \[[@B17],[@B20]-[@B22]\]. RT-LAMP is more sensitive than the conventional RT-PCR and more convenient than real-time RT-PCR. Another advantage of this assay is that the results can be examined by inspection of color change and examination with agarose gel electrophoresis. Consistence results observed by both methods in this study indicate that a visual inspection is sufficient for a routine test \[[@B23]\]. This is particular useful and can be extremely convenient in a large scale screening process.

In clinical specimens, 93.8% was positive for vvIBDV infection, indicating the severity of vvIBDV infection in many areas of China. Even though vaccination has been widely adopted, vvIBDV can break through high levels of maternal antibodies in commercial flocks \[[@B24],[@B25]\]. Since vaccine was produced by attenuated or classical strains, it is very important and significant that wild isolates of vvIBDV can be distinguished from vaccinated strains.

Sequence analysis showed a SNP in the target sequence of RT-LAMP among IBDV strains. \"A\" is conserved in classical, attenuated, variant and serotype II strains, creating a Tfi I site in this site, while it is substituted by \"T\" in typical vvIBDV strains except UK661 that has a \"C\". Since this SNP was identified from strains with a wide geographic distribution, so the Tfi I digestion based on this SNP should be reliable and generally work. Although the VP5 of infectious bursal disease virus has been reported to contribute to rival virulence and viral release \[[@B26],[@B27]\], the role of this nucleotide substitution in viral pathogenesis is still unknown. We are yet to determine whether this point mutant may be involved in the virulence or viral release, or it may just be a unique nucleotide tag between vvIBDV and non-vvIBDVs.

Conclusion
==========

In summary, one-step RT-LAMP is a rapid, efficient, sensitive and highly specific assay for the identification of IBDV. In combination with Tfi I restriction analysis, vvIBDV strain can be discriminated from non-vvIBDVs. Owning to these properties, this method showed great promises not only in laboratory test but also in the field and clinical applications.
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